# Check-Cap Ltd. (CHEK)

**Exchange:** NASDAQ  
**Sector:** Healthcare  
**Market cap:** $9M  
**Price:** $1.53 (-8.38%)

> Check-Cap Ltd. is a pioneering healthcare technology company specializing in the development of innovative screening solutions for colorectal cancer. The company is renowned for its advanced capsule-based screening platform designed to detect polyps and abnormal growths in the colon. Unlike traditional methods, the Check-Cap screening platform does not require bowel preparation, thus making it a more patient-friendly alternative. Check-Cap is continuing to make strides in the healthcare industry by providing a non-invasive, radiation-free screening method, aiming to increase participation rates in colorectal cancer screening. By focusing on early detection and patient compliance, Check-Cap plays a vital role in the preventive care segment of the medical field, potentially improving patient outcomes and reducing healthcare costs associated with late-stage colorectal cancer diagnosis. Its groundbreaking technology is of significant interest to healthcare providers and regulators seeking efficient, patient-centered diagnostic solutions, highlighting its significance in the ongoing efforts to combat a major health concern worldwide.

## Income Statement (Annual, USD)

| Fiscal Year | Revenue | Gross Profit | Operating Income | Net Income | EPS (dil.) |
| --- | --- | --- | --- | --- | --- |
| 2024 | — | — | -$9M | -$25M | $-4.30 |
| 2023 | — | — | -$18M | -$18M | $-3.00 |
| 2022 | — | — | -$20M | -$19M | $-3.37 |
| 2021 | — | — | -$17M | -$17M | $-4.20 |
| 2020 | — | — | -$14M | -$14M | $-9.20 |
| 2019 | — | — | -$14M | -$14M | $-34.60 |

## Balance Sheet (Annual, USD)

| Fiscal Year | Total Assets | Total Liabilities | Equity | Cash | Long-term Debt |
| --- | --- | --- | --- | --- | --- |
| 2024 | $377,000 | $2M | -$1M | — | $16,000 |
| 2023 | $25M | $1M | $24M | $9M | — |
| 2022 | $45M | $4M | $41M | $4M | $627,000 |
| 2021 | $56M | $5M | $51M | $26M | $795,000 |
| 2020 | $20M | $3M | $16M | $8M | $125,000 |
| 2019 | $9M | $3M | $6M | $8M | $211,000 |

## Cash Flow (Annual, USD)

| Fiscal Year | Operating Cash Flow | CapEx | Free Cash Flow |
| --- | --- | --- | --- |
| 2024 | -$25M | — | -$8M |
| 2023 | -$18M | -$83,000 | -$17M |
| 2022 | -$18M | -$486,000 | -$19M |
| 2021 | -$16M | -$1M | -$17M |
| 2020 | -$14M | -$379,000 | -$13M |
| 2019 | -$13M | -$167,000 | -$13M |

Source: [CompaniesByCap](https://companiesbycap.com/company/CHEK)